XSUS:CA:TSX-iShares ESG MSCI USA Index (CAD)

ETF | US Equity |

Last Closing

CAD 40.66

Change

-0.10 (-0.25)%

Market Cap

CAD 0.48B

Volume

3.90K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-18 )

Largest Industry Peers for US Equity

Symbol Name Price(Change) Market Cap
VFV:CA Vanguard S&P 500 Index ETF

-0.19 (-0.14%)

CAD 16.35B
ZSP:CA BMO S&P 500

-0.07 (-0.08%)

CAD 15.56B
XSP:CA iShares Core S&P 500 (CAD Hedg..

-0.18 (-0.31%)

CAD 10.26B
VUN:CA Vanguard US Total Market

-0.05 (-0.05%)

CAD 9.10B
XUS:CA iShares Core S&P 500 Index ETF

-0.06 (-0.13%)

CAD 7.07B
HXS:CA Global X S&P 500 Corporate Cla..

-0.10 (-0.13%)

CAD 3.88B
VSP:CA Vanguard S&P 500 CAD hedged

-0.25 (-0.27%)

CAD 3.35B
QUU:CA Mackenzie US Large Cap Equity ..

-0.52 (-0.24%)

CAD 3.20B
XUU:CA iShares Core S&P US Total Mark..

+0.03 (+0.05%)

CAD 2.96B
XQQ:CA iShares NASDAQ 100 (CAD Hedged..

-0.21 (-0.43%)

CAD 2.85B

ETFs Containing XSUS:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (US Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 21.66% 90% A- 82% B
Dividend Return 0.50% 19% F 15% F
Total Return 22.17% 90% A- 81% B-
Trailing 12 Months  
Capital Gain 29.00% 83% B 81% B-
Dividend Return 1.18% 31% F 25% F
Total Return 30.18% 85% B 80% B-
Trailing 5 Years  
Capital Gain 91.79% 79% B- 86% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 91.79% 72% C 84% B
Average Annual (5 Year Horizon)  
Capital Gain 13.65% 78% C+ 80% B-
Dividend Return 14.44% 78% C+ 78% C+
Total Return 0.79% 20% F 33% F
Risk Return Profile  
Volatility (Standard Deviation) 14.38% 44% F 56% F
Risk Adjusted Return 100.44% 71% C- 97% N/A
Market Capitalization 0.48B 53% F 58% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.